Allogeneic hematopoietic stem cell transplantation for the treatment of chronic myeloid leukemia in blast crisis / 白血病·淋巴瘤
Journal of Leukemia & Lymphoma
; (12): 330-335, 2013.
Article
in Zh
| WPRIM
| ID: wpr-458050
Responsible library:
WPRO
ABSTRACT
The treatment for chronic myeloid leukemia is still a challenge,at present.Tyrosine kinase inhibitors can partially control chronic myeloid leukemia in blast crisis (CML-BC),but the effect is not durable.Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the only way that can cure CML-BC.This paper presents a review of the treatment before allo-HSCT for CML-BC,the selection of condition regimen,donor and hematopoietic stem cell,the monitoring of MRD post-transplant,the prophylaxis and intervention of relapse.
Full text:
1
Index:
WPRIM
Language:
Zh
Journal:
Journal of Leukemia & Lymphoma
Year:
2013
Type:
Article